Research
Search in biosurfit Start writing...
company

how a real problem became an everyday solution.

Company
biosurfit is a diagnostics and biotechnology company focused on the development, manufacture, and distribution of IVD tests for the point-of-care market with highly innovative proprietary technology and dedicated to provide comprehensive contract development and manufacturing services.

Our flagship product, the spinit® platform, integrates multiple diagnostic tests into a single device, delivering rapid and accurate results for healthcare professionals. Committed to improving patient outcomes, biosurfit combines cutting-edge research with practical applications to offer reliable, efficient, and user-friendly point-of-care diagnostic solutions. 

We specialize in providing contract development and manufacturing services, leveraging our extensive portfolio of patents and expertise in microfluidics. Our commitment to innovation and excellence makes biosurfit a trusted partner for companies seeking advanced, turnkey manufacturing solutions in the healthcare industry.

Mission

At biosurfit we work every day to shape the future of in-vitro diagnostic testing. 

We want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients.
Mission

Values

At biosurfit, our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. 
Our best assets are Innovative, Excellent, Responsible and Fair.

biosurfit guides its activities under an impeccable and socially responsible code of ethical conduct. This can be seen in all our internal and external relationships with employees, shareholders, customers, suppliers, universities and partners, public entities, official entities, press or public. biosurfit´s ethical conduct is practised daily by all of its’ employees while performing their daily activities.
Values

our track record

2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
2006
biosurfit wins ANJE (Associação Nacional de Jovens Empresários) entrepreneur of the year
2009
biosurfit receives ISO9001: 2008 & ISO13485:2004 certification from TÜV Rheinland
2010
biosurfit wins “Hospital do Futuro” award
2010
biosurfit receives the results of the “Point of care medical test market research”, project delivered by IMS Healthcare
2011
biosurfit wins the “Growth Companies Competition” in the HiTBarcelona -World Innovation Summit.
2012
Semi-automated production line validated
2012
biosurfit gets CE Marking of the spinit® instrument and the first test, spinit® CRP for quantitative measurement of C-Reactive Protein in blood
2013
biosurfit wins Start-up of the Year award from Portugal Ventures
2013
biosurfit was present at MEDICA, the world’s largest Medicine Forum, for the first time as an exhibitor
2013
June: first distribution agreement signed with Rev Diagnostics, The Netherlands
2013
Awarded €1.4m grant by the European Commission’s 7th Framework Programme
2014
May: biosurfit receives CE Mark for spinit® Blood Count test
2014
February: biosurfit’ s first commercial sale in the Netherlands
2015
biosurfit secures €12 million loan from the European Investment Bank
2015
biosurfit wins “Live Sciences & Med Tech Venture of the Year” from Portugal Ventures
2015
biosurfit secures €4.3 of public funding from the European Union program PT2020
2016
biosurfit receives CE mark for the spinit® HbA1c test
2016
Several distribution contracts signed in Europe
2016
spinit® launched in 13 different countries
2017
IFCC and NGSP certification for spinit® HbA1c
2017
biosurfit wins award of distinction “BORN FROM KNOWLEDGE” at the 14th National Meeting of Innovation COTEC-ANI
2017
new manufacturing facility in Azambuja
2017
biosurfit achieves a significant commercial milestone - 500 spinit® Instruments placed with European Customers
2018
New website launch
2018
biosurfit receives Innovation Award at the first edition of the EIB Venture Debt Summit
2018
biosurfit signs strategic Partnership - €10 million of equity financing from Boule Diagnostics and 200M co-investment fund
2019
biosurfit launches new sample collection method | spinit® strip
2019
Launch of spinit® CRP and spinit® HbA1c controls solution.
2020
smart triage in partnership with the Red Cross
2020
Opening of the first Smart Triage mobile unit in Azambuja Opening of a mobile unit in Telheiras, Corroios and Cascais
2020
Development of the COVID Checked brand for testing solutions in mobile units
2021
biosurfit receives CE mark for the spinit® COVID-19 test

Meet OUR TEAM

We are a young, dynamic and diverse team of people from different backgrounds from PhD’s, engineers, biotechnology, IT, management, commercial and financial, marketing and production who work every day with the same purpose. 

We are committed in making a difference in the medical diagnostics industry, helping people to achieve a better quality of life so they can enjoy it the best possible way. 


Meet OUR TEAM

management team

Chairman

João Garcia da Fonseca

  • Founder and CEO of biosurfit (2006); 
  • Strong scientific background, multiple publications in top peer-reviewed journals of applied physics, author of more than 21 patents related to the spinit® technology; 
  • Recognised for his work with various awards, notably Portuguese Young Entrepreneur of the Year in 2007; 
  • Previously founder and CEO of LCT, a start-up company developing technologies for bi-stable liquid crystal displays; 
  • PhD in Physics Engineering, Louis Pasteur University, Strasbourg; Degree in Physics Engineering from Technical University of Lisbon. 

Chief Executive Officer

Rosa Santos

  • Finance Director at biosurfit since 2014; 
  • 10+ years of management positions in financial, sales and project management direction;
  • Post-graduation in Tax Management by ISG; 
  • Degree in Banking and Insurance Management, Finance and Accounting by ISCAL; 
  • Black Belt certification (Lean Six Sigma methodology). 
Failed to load the Page Fonts We apologize, but the user experience may not be the best! Got it